These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 16688194

  • 1. Steroid resistance in childhood nephrotic syndrome.
    Berns JS, Siegel NJ.
    Kidney Int; 2006 May; 69(10):1915-6. PubMed ID: 16688194
    [No Abstract] [Full Text] [Related]

  • 2. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA, Levtchenko EN, Wetzels JF.
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
    Hafeez F, Ahmad TM, Anwar S.
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 5. Treatment of steroid resistant nephrotic syndrome in children.
    Kari JA, Halawani M.
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):484-7. PubMed ID: 20427873
    [Abstract] [Full Text] [Related]

  • 6. Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome.
    Uldall PR, Feest TG, Morley AR, Tomlinson BE, Kerr DN.
    Lancet; 1972 Jun 10; 1(7763):1250-3. PubMed ID: 4113514
    [No Abstract] [Full Text] [Related]

  • 7. Long-term outcome of the difficult nephrotic syndrome in children.
    Al Salloum AA, Muthanna A, Bassrawi R, Al Shehab AA, Al Ibrahim A, Islam MZ, Al Hasan K.
    Saudi J Kidney Dis Transpl; 2012 Sep 10; 23(5):965-72. PubMed ID: 22982908
    [Abstract] [Full Text] [Related]

  • 8. [Good results of cyclophosphamide in steroid toxicity in the treatment of nephrotic syndrome caused by minimal-lesion glomerulopathy in childhood].
    de Moor R, de Jong M, Monnens L.
    Ned Tijdschr Geneeskd; 1992 May 02; 136(18):876-80. PubMed ID: 1589052
    [Abstract] [Full Text] [Related]

  • 9. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
    Gulati S, Prasad N, Sharma RK, Kumar A, Gupta A, Baburaj VP.
    Nephrol Dial Transplant; 2008 Mar 02; 23(3):910-3. PubMed ID: 18039644
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.
    Cammas B, Harambat J, Bertholet-Thomas A, Bouissou F, Morin D, Guigonis V, Bendeddouche S, Afroukh-Hacini N, Cochat P, Llanas B, Decramer S, Ranchin B.
    Nephrol Dial Transplant; 2011 Jan 02; 26(1):178-84. PubMed ID: 20610527
    [Abstract] [Full Text] [Related]

  • 11. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
    Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P.
    Nephrol Dial Transplant; 1993 Jan 02; 8(12):1326-32. PubMed ID: 8159300
    [Abstract] [Full Text] [Related]

  • 12. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A, Chongchate N, Suntornpoch V, Pattaragarn A, Supavekin S.
    J Med Assoc Thai; 2005 Nov 02; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [Abstract] [Full Text] [Related]

  • 13. Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome revisited.
    Seibert FS, van der Giet M, Zidek W, Westhoff TH.
    Clin Nephrol; 2012 Apr 02; 77(4):345-6. PubMed ID: 22445479
    [No Abstract] [Full Text] [Related]

  • 14. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
    Kidney Int; 2012 Nov 02; 82(10):1130-5. PubMed ID: 22763815
    [Abstract] [Full Text] [Related]

  • 15. Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids.
    Youssef DM, Attia TA, El-Shal AS, Abduelometty FA.
    Gene; 2013 Nov 10; 530(2):201-7. PubMed ID: 23994685
    [Abstract] [Full Text] [Related]

  • 16. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
    Bailey RR.
    N Z Med J; 1989 Jul 26; 102(872):379-81. PubMed ID: 2797556
    [Abstract] [Full Text] [Related]

  • 17. [Clinicopathological studies on steroid-responsive nephrotic syndrome in children--long-term follow up studies].
    Hirabayashi K.
    Nihon Jinzo Gakkai Shi; 1975 Dec 26; 17(12):1005-20. PubMed ID: 1241988
    [No Abstract] [Full Text] [Related]

  • 18. Cyclophosphamide therapy in idiopathic nephrotic syndrome--a new treatment.
    Dundon S, Carroll R, Dunleavy M, Raftery J.
    J Ir Med Assoc; 1971 May 13; 64(411):243-6. PubMed ID: 5578246
    [No Abstract] [Full Text] [Related]

  • 19. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY, Wu CY, Tsai IJ, Tsau YK.
    Nephrology (Carlton); 2010 Apr 13; 15(3):336-9. PubMed ID: 20470303
    [Abstract] [Full Text] [Related]

  • 20. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov 13; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.